Regulating the Hallucinogens
The hallucinogens (including, for this purpose, MDMA and its relatives), have been or could be used to treat disease, to generate spiritual experience both individually and communally, and to enhance creativity, in addition to their recreational/social uses. Those four uses suggest different regulatory approaches. Neither
the risks nor the beneﬁts associated with hallucinogen use are sufﬁciently close to those of alcohol or of the other classes of controlled drugs to allow a simple appropriation of existing regulatory schemes.
This video is from Psychedelic Science in the 21st Century, a conference taking in place in San Jose, California on April 15-18, 2010. The conference was organized by the Multidisciplinary Association for Psychedelic Studies (MAPS) in collaboration with the Heffter Research Institute, the Council on Spiritual Practices, and the Beckley Foundation.
This video was produced by Green Fuse Media, contact Nathan at email@example.com
To learn more about MAPS or to support our work, visit maps.org.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?